Literature DB >> 17425414

Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations.

T Mazda1, R Yabe, O NaThalang, T Thammavong, K Tadokoro.   

Abstract

Passively transfused blood group antibodies cause clinical problems. High titers of anti-A and anti-B seem to be one reason for hemolytic transfusion reactions and for ABO HDN. In Japan, anti-A and anti-B titers notably decreased in the 15 years between 1986 and 2001. At present, titers of more than 100,as measured using the saline method, are rare. Differences in the level of anti-A and anti-B among ethnic populations have been reported; these differences were found to be the result of environmental factors rather than hereditary factors. In the present study, the anti-A and anti-B titers of random donors in three Asian populations are compared. In Thailand, the IgM anti-A and anti-B titers are low and are similar to the Japanese titers reported in 2001, but the IgG anti-A and anti-B titers are high and are similar to the Japanese titers reported in 1986. In the Lao People's Democratic Republic, both the IgM and the IgG anti-A and anti-B titers are high and are similar to those reported in Japan in 1986. In addition, anti-A and anti-B titers of different sex donors and of various age groups were also compared. High titers were found in 8.8 percent of the female donors in the younger than 30 age group and in 36.7 percent of the female donors in the older than 50 age group.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425414

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  11 in total

1.  Evaluation of Magnetized-Erythrocyte Group Antigens to Detect ABO Antibodies.

Authors:  O Nathalang; K Intharanut; P Sriwanitchrak; M Setthakarn; S Duan; H Wang; S Ding; Y Li
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-29       Impact factor: 0.900

2.  The characteristics of ABO antibodies in group O Thai blood donors.

Authors:  Kamontip Khampanon; Thanaporn Chanprakop; Pramote Sriwanitchrak; Manida Setthakarn; Sineenart Oota; Oytip Nathalang
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 3.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Antibody titers in Group O platelet donors.

Authors:  Anita Amar Tendulkar; Puneet Ashok Jain; Sanjay Velaye
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun

Review 5.  ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data.

Authors:  Jacques Le Pendu; Adrien Breiman; Jézabel Rocher; Michel Dion; Nathalie Ruvoën-Clouet
Journal:  Viruses       Date:  2021-01-22       Impact factor: 5.048

6.  A case of IgM deficiency with B cell deficiency detected by ABO discrepancy in a patient with acute osteomyelitis.

Authors:  Chae Lim Jung; Mi-Kyung Cha; Byoung-Hyuk Jun; Ki-Sook Hong
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

7.  Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge.

Authors:  Gregory Denomme
Journal:  Rev Bras Hematol Hemoter       Date:  2011

8.  Titers of ABO antibodies in group O blood donors.

Authors:  Natalia Dallaval Galvão de França; Mônica Caamaño Cristovão Poli; Patrícia Guilhem de Almeida Ramos; Cláudia Strang da Rocha Borsoi; Rafael Colella
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Risk Factors, Coronary Severity, Outcome and ABO Blood Group: A Large Chinese Han Cohort Study.

Authors:  Yan Zhang; Sha Li; Cheng-Gang Zhu; Yuan-Lin Guo; Na-Qiong Wu; Rui-Xia Xu; Qian Dong; Geng Liu; Jian-Jun Li
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  Relationship of SARS-CoV-2 Pandemic with Blood Groups.

Authors:  Didar Yanardag Acik; Mehmet Bankir
Journal:  Transfus Med Hemother       Date:  2021-04-07       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.